MARKET

GCTK

GCTK

Glucotrack
NASDAQ
0.1460
-0.0027
-1.82%
After Hours: 0.1460 0 0.00% 19:56 05/13 EDT
OPEN
0.1509
PREV CLOSE
0.1487
HIGH
0.1509
LOW
0.1430
VOLUME
11.79M
TURNOVER
--
52 WEEK HIGH
62.60
52 WEEK LOW
0.1313
MARKET CAP
3.74M
P/E (TTM)
-0.0021
1D
5D
1M
3M
1Y
5Y
1D
GlucoTrack Gains Approval for Long-Term Clinical Study
TipRanks · 13h ago
GlucoTrack receives ethical approval from St. Vincent’s HREC for CBGM study
TipRanks · 14h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 14h ago
GLUCOTRACK ANNOUNCES ETHICAL APPROVAL FOR LONG-TERM CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
Reuters · 14h ago
Weekly Report: what happened at GCTK last week (0505-0509)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 05/06 12:08
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 05/05 21:05
Weekly Report: what happened at GCTK last week (0428-0502)?
Weekly Report · 05/05 10:23
More
About GCTK
More
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
Recently
Symbol
Price
%Change

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.